Identification of histamine releasing factor(s) in the late phase of cutaneous IgE-mediated reactions
- PMID: 2419443
Identification of histamine releasing factor(s) in the late phase of cutaneous IgE-mediated reactions
Abstract
We have shown that fluids collected from antigen-challenged skin blisters during the late phase reaction cause the release of substantial amounts of histamine (means = 42%, n = 14) from human basophils in vitro. Control fluids collected either during the immediate phase or from an unchallenged blister released less than or equal to 10% histamine from both basophils and lung mast cells. Late phase blister fluids induced low levels of histamine release from human lung cells (means = 11%, n = 4) that were slightly but not significantly greater than levels induced by control blister fluids. The characteristics of basophil release were similar to IgE-mediated stimuli in dose dependence, calcium and temperature requirements, and kinetics. The IgE dependence of the late phase blister fluid was demonstrated by desensitization of the basophils to anti-IgE, which obviated the response to anti-IgE and blister fluid but did not affect a non-IgE-mediated stimulus. Removal of the cell surface IgE with lactic acid also abolished the response to both anti-IgE and late phase blister fluid. Incubation of the "stripped" cells with serum containing IgE myeloma restored the response to anti-IgE but failed to affect response to late phase blister fluid. The characteristics of release obtained with this factor closely resemble those of an IgE-dependent histamine releasing factor from cultured macrophages previously described by our group.
Similar articles
-
Human lung macrophage-derived histamine-releasing activity is due to IgE-dependent factors.J Immunol. 1986 Apr 1;136(7):2588-95. J Immunol. 1986. PMID: 2419444
-
Studies of IgE-dependent histamine releasing factors: heterogeneity of IgE.J Immunol. 1987 Jul 15;139(2):506-12. J Immunol. 1987. PMID: 2439589
-
Recombinant IL-3 induces histamine release from human basophils.J Immunol. 1989 May 15;142(10):3527-32. J Immunol. 1989. PMID: 2469718
-
Basophil-mast cell response syndromes: a unified clinical approach.Allergy Proc. 1988 Nov-Dec;9(6):611-20. doi: 10.2500/108854188778965410. Allergy Proc. 1988. PMID: 3066689 Review.
-
Histamine-releasing factors and inhibitors: historical perspectives and possible implications in human illness.J Allergy Clin Immunol. 1991 Nov;88(5):683-93. doi: 10.1016/0091-6749(91)90170-s. J Allergy Clin Immunol. 1991. PMID: 1720148 Review.
Cited by
-
Cutaneous late-phase response to allergen. Mediator release and inflammatory cell infiltration.J Clin Invest. 1989 May;83(5):1519-26. doi: 10.1172/JCI114047. J Clin Invest. 1989. PMID: 2468688 Free PMC article.
-
The effects of overexpression of histamine releasing factor (HRF) in a transgenic mouse model.PLoS One. 2010 Jun 11;5(6):e11077. doi: 10.1371/journal.pone.0011077. PLoS One. 2010. PMID: 20552026 Free PMC article.
-
Nasal hyperreactivity and inflammation in allergic rhinitis.Mediators Inflamm. 1996;5(2):79-94. doi: 10.1155/S0962935196000142. Mediators Inflamm. 1996. PMID: 18475703 Free PMC article.
-
Proton pump inhibitors exert anti-allergic effects by reducing TCTP secretion.PLoS One. 2009 Jun 1;4(6):e5732. doi: 10.1371/journal.pone.0005732. PLoS One. 2009. PMID: 19484128 Free PMC article.
-
The IgE receptor of eosinophils.Springer Semin Immunopathol. 1990;12(4):327-48. doi: 10.1007/BF00225322. Springer Semin Immunopathol. 1990. PMID: 2151403 Review. No abstract available.